Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine.
about
Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies.Effect of intensive multifactorial treatment on vascular progenitor cells in hypertensive patients.Treatment with triple combination of atorvastatin, perindopril, and amlodipine in patients with stable coronary artery disease: A subgroup analysis from the PAPA-CAD study.Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Pr
P2860
Triple Combination Therapy for Global Cardiovascular Risk: Atorvastatin, Perindopril, and Amlodipine.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Triple Combination Therapy for ...... , Perindopril, and Amlodipine.
@en
type
label
Triple Combination Therapy for ...... , Perindopril, and Amlodipine.
@en
prefLabel
Triple Combination Therapy for ...... , Perindopril, and Amlodipine.
@en
P2093
P2860
P1476
Triple Combination Therapy for ...... , Perindopril, and Amlodipine.
@en
P2093
Charalambos Vlachopoulos
Jean-Jacques Mourad
Michel E Bertrand
P2860
P2888
P304
P356
10.1007/S40256-016-0175-2
P577
2016-06-02T00:00:00Z
P6179
1036227717